Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 20 Source: CRO
- €557.6 million turnover
-
-€100.2 million
profit - 363 employees
-
31st Dec 19 Source: CRO
- €645.4 million turnover
-
-€138.8 million
profit - 361 employees
- 8 more years available »
Ranking
By Turnover
(€557.6 million)- 155th in Top Companies
- 21st in Health
- 19th in Pharma
By Employees
(363)- 445th in Top Companies
- 67th in Health
- 42nd in Pharma
-
- 363
- €557.6 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- May 24 Harsh winter may compel Europe to ration gas, warns International Energy Agency
- May 24 Hungary and Poland hold up EU decisions on oil and corporate tax
- May 24 Over 700 objections lodged against €466m Dundrum apartment ‘concrete jungle’
- May 24 Stripe unveils new third party app marketplace
- May 24 Shares in UK energy companies slide over windfall tax fears